Core Viewpoint - 康臣药业 has been actively repurchasing its shares, indicating a strategy to support its stock price amidst recent declines [2][3]. Share Buyback Summary - On December 3, 康臣药业 repurchased 290,000 shares at a price range of HKD 14.660 to HKD 14.740, totaling HKD 4.2674 million [2]. - The stock closed at HKD 14.740 on the same day, reflecting a decrease of 1.54%, with a total trading volume of HKD 15.2119 million [2]. - Since December 2, the company has conducted buybacks for two consecutive days, acquiring a total of 490,000 shares for a cumulative amount of HKD 7.2518 million, during which the stock price fell by 2.38% [2]. Year-to-Date Buyback Activity - Year-to-date, 康臣药业 has executed 50 buyback transactions, acquiring a total of 12.078 million shares for a total expenditure of HKD 161 million [3].
康臣药业(01681.HK)连续2日回购，累计斥资725.18万港元